DocuSign, Inc. (DOCU)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is February - January.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Market Capitalization	14,918	19,542	12,423	12,193	24,887	44,542
Market Cap Growth	42.85%	57.31%	1.88%	-51.01%	-44.13%	216.15%
Enterprise Value	14,102	18,730	11,668	12,056	24,970	44,629
Last Close Price	73.83	96.73	60.92	60.64	125.77	232.89
PE Ratio	14.07	18.30	167.92	-	-	-
Forward PE	20.53	26.54	21.91	29.11	61.48	235.74
PS Ratio	4.96	6.57	4.50	4.85	11.81	30.65
PB Ratio	7.40	9.76	11.00	19.75	90.33	136.74
P/TBV Ratio	10.01	13.28	17.12	63.05	-	-
P/FCF Ratio	16.29	21.23	14.00	28.42	55.92	207.60
P/OCF Ratio	14.71	19.21	12.68	24.06	49.14	150.00
PEG Ratio	1.50	0.95	0.77	2.13	1.34	5.89
EV/Sales Ratio	4.65	6.29	4.22	4.79	11.85	30.71
EV/EBITDA Ratio	47.76	65.35	95.09	1516.61	1684.00	-
EV/EBIT Ratio	58.16	80.05	185.98	-	-	-
EV/FCF Ratio	15.40	20.35	13.15	28.10	56.10	208.00
Debt / Equity Ratio	0.07	0.06	0.13	1.44	3.20	2.81
Debt / EBITDA Ratio	0.42	0.40	0.95	21.59	17.92	-
Debt / FCF Ratio	0.14	0.14	0.16	2.07	1.98	4.27
Asset Turnover	0.88	0.85	0.92	0.91	0.86	0.69
Quick Ratio	0.73	0.77	0.90	0.71	0.92	1.02
Current Ratio	0.79	0.81	0.94	0.74	0.96	1.06
Return on Equity (ROE)	70.20%	68.18%	8.47%	-21.83%	-23.28%	-55.79%
Return on Assets (ROA)	4.41%	4.19%	1.31%	-1.32%	-1.46%	-5.14%
Return on Capital (ROIC)	8.86%	8.60%	2.82%	-2.75%	-2.96%	-8.92%
Return on Capital Employed (ROCE)	11.00%	10.70%	4.80%	-	-	-
Earnings Yield	7.42%	5.46%	0.60%	-0.80%	-0.28%	-0.55%
FCF Yield	6.14%	4.71%	7.14%	3.52%	1.79%	0.48%
Buyback Yield / Dilution	-0.79%	-0.66%	-4.00%	-2.15%	-5.88%	-5.13%

Updated Jun 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q